Uterine artery Doppler to predict growth restriction in cases of abnormal first trimester analytes

被引：3

作者：

Jones, Sara L. ^{[1
,2
,3
]}

Aviram, Amir ^{[1
]}

Porto, Ludmila ^{[1
]}

Huang, Tianhua ^{[4
,5
,6
]}

Satkunaratnam, Abheha ^{[2
]}

Barrett, Jon F. R. ^{[1
]}

Melamed, Nir ^{[1
]}

Mei-Dan, Elad ^{[2
]}

机构：

[1] Univ Toronto, Div Maternal Fetal Med, Dept Obstet & Gynecol, Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada

[2] Univ Toronto, North York Gen Hosp, Dept Obstet & Gynecol, Toronto, ON, Canada

[3] Dalhousie Univ, Dalhousie Med Sch, Halifax, NS, Canada

[4] North York Gen Hosp, Genet Program, Toronto, ON, Canada

[5] Better Outcomes Registry & Network BORN Ontario, Prenatal Screening Ontario, Ottawa, ON, Canada

[6] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada

来源：

PLACENTA | 2021年 / 106卷

关键词：

Antenatal care; Doppler ultrasound; Serum screening; MATERNAL SERUM ANALYTES; PAPP-A; PREECLAMPSIA; PREGNANCY; MARKERS; COMPLICATIONS; GESTATION; PROTEIN;

D O I：

10.1016/j.placenta.2021.02.004

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

We retrospectively included women with abnormal FTS analytes and compared outcomes between those with elevated and normal UtA PI. Out of 582 women with abnormal FTS analytes, 65 (11.2%) had elevated UtA PI. Neonates of women in this group had higher rates of birth weight <3rd, 5th, and 10th percentile. The area under the ROC curve for predicting FGR <10th percentile by UtA-PI was 0.584, for FGR<5th percentile 0.593, and for FGR<3rd percentile 0.720. In women with abnormal FTS, elevated UtA-PI is associated with higher rates of FGR, but its predictability is moderate-to-poor.

引用

页码：22 / 24

页数：3

共 19 条

[1] Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia
Akolekar, R.
Zaragoza, E.
Poon, L. C. Y.
Pepes, S.
Nicolaides, K. H.
[J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2008, 32 (06) : 732 - 739
[2] Albu A R, 2014, J Med Life, V7, P165
[3] Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis
Allen, Rebecca E.
Rogozinska, Ewelina
Cleverly, Kirsty
Aquilina, Joseph
Thangaratinam, S.
[J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2014, 182 : 194 - 201
[4] First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)
Dugoff, L
Hobbins, JC
Malone, FD
Porter, TF
Luthy, D
Comstock, CH
Hankins, G
Berkowitz, RL
Merkatz, I
Craigo, SD
Timor-Tritsch, IE
Carr, SR
Wolfe, HM
Vidaver, J
D'Alton, ME
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (04) : 1446 - 1451
[5] Ertan AK., 2013, DONALD SCH J ULTRASO, V7, P128
[6] Obstetrical Complications Associated With Abnormal Maternal Serum Markers Analytes
Gagnon, Alain
Wilson, R. Douglas
Audibert, Francois
Allen, Victoria M.
Blight, Claire
Brock, Jo-Ann
Desilets, Valerie A.
Johnson, Jo-Ann
Langlois, Sylvie
Summers, Anne
Wyatt, Philip
[J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2008, 30 (10) : 918 - 932
[7] Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG
Goetzinger, Katherine R.
Singla, Ashima
Gerkowicz, Sabrina
Dicke, Jeffrey M.
Gray, Diana L.
Odibo, Anthony O.
[J]. PRENATAL DIAGNOSIS, 2010, 30 (12-13) : 1138 - 1142
[8] First trimester screening for Down syndrome using nuchal translucency, maternal serum pregnancy-associated plasma protein A, free- human chorionic gonadotrophin, placental growth factor, and -fetoprotein
Huang, Tianhua
Dennis, Alan
Meschino, Wendy S.
Rashid, Shamim
Mak-Tam, Ellen
Cuckle, Howard
[J]. PRENATAL DIAGNOSIS, 2015, 35 (07) : 709 - 716
[9] First-Trimester Uterine Artery Doppler Analysis in the Prediction of Later Pregnancy Complications
Khong, Su Lynn
Kane, Stefan C.
Brennecke, Shaun P.
Costa, Fabricio da Silva
[J]. DISEASE MARKERS, 2015, 2015 : 1 - 10
[10] Maternal serum analytes as markers of adverse obstetric outcome
Lakhi, Nisha
Govind, Abha
Moretti, Michael
Jones, Johannes
[J]. OBSTETRICIAN & GYNAECOLOGIST, 2012, 14 (04) : 267 - 273

← 1 2 →